The Projects and Skills Providing Optionality and Flexibility Amid Uncertainty
The 2023 High-End Independent Talent Report—an annual analysis of how business leaders in pharmaceuticals and other industries are deploying independent consultants, subject matter experts, project managers, and interim executives to fill critical skill, expertise, and leadership gaps—uncovers how companies are seeking optionality and flexibility amid economic uncertainty.
Following the rapid development of COVID-19 vaccines, the pharma industry is in a transformative period fueled by advances in AI, personalized medicine, and connected wearable devices and digital platforms—as well as by regulatory change and the rise of value-based contracting.
As long-time innovators in the use of on-demand talent, pharma leaders rely on independents to help them stay competitive and keep up with a rapidly changing industry.
Download the report to see the:
Offered Free by: Business Talent Group
See All Resources from: Business Talent Group
This download should complete shortly. If the resource doesn't automatically download, please, click here.